Ruxolitinib improves hematocrit control and treatment response in polycythemia vera compared to best available therapy. Patients on ruxolitinib show better Myeloproliferative Neoplasms-Symptom ...
Nuvisertib received FDA fast track designation for myelofibrosis, showing significant clinical activity in symptom and spleen response, and improvements in bone marrow fibrosis, hemoglobin, and ...
In this fourth part of a discussion with The American Journal of Managed Care®, Andrew Kuykendall, MD, clinical researcher at Moffitt Cancer Center and VERIFY investigator, speaks to the impressive ...
Please provide your email address to receive an email when new articles are posted on . Rusfertide reduced need for phlebotomies and offered better hematocrit control than placebo. Results showed ...
Dr. Aaron Gerds explained when treatment with rusfertide will become accessible for patients with a myeloproliferative neoplasm like polycythemia vera. Dr. Aaron Gerds sat down for an interview with ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
On Monday, Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and Takeda Pharmaceutical Co Ltd (NYSE:TAK) released topline results for the Phase 3 VERIFY study of rusfertide for polycythemia vera.
Verywell Health on MSN
What to know about polycythemia vera and COVID-19
Medically reviewed by Anju Goel, MD Key Takeaways People with polycythemia vera should not skip phlebotomy appointments to manage their condition.People with blood disorders like PV may have a higher ...
The risk of venous and arterial thrombosis in polycythemia vera patients with secondary malignancies. Temporal trends in myeloproliferative neoplasms–related mortality in the United States over the ...
CHICAGO -- The use of the investigational weekly subcutaneous injection rusfertide significantly reduced the need for phlebotomy among polycythemia vera patients who had been dependent on it, the ...
DEAR DR. ROACH: My husband (age 71) received a diagnosis of polycythemia vera a few years ago. I understand this variety of polycythemia isn’t caused by smoking, but we know that smoking does make it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results